XOStem founders and scientists have decades of combined experience in adult stem cell science, with particular emphasis on bone marrow and umbilical cord derived mesenchymal stem cells.learn more
XOStem is dedicated to developing Engineered Exosome therapies that address pressing medical needs, especially ones with ruinous impact on quality of life that affect large populations.
A major research direction at XOStem, Inc. is refinement and deployment of a breakthrough approach to the treatment of Type 1 diabetes, first in companion pets and later in humans.
XOStem scientists are globally recognized experts in diabetes, pancreatic islet, stem cell and exosome science. Much of the foundational science behind XOStem technologies is the result of years of animal research performed by our scientific team. Islet and stem cell research in rodent, dog, swine, and primate models provide much of the foundational science supporting XOStem technologies. Decades of association with domestic and foreign peers create opportunities for scientific collaboration around the world.
Examples of animal study collaborations currently underway include:
Contract terms stipulate that XOStem owns all intellectual property that results from the above collaborations.